From hypothesis to filing, faster
Syntic AI Employees accelerate research, regulatory, and medical affairs — synthesizing literature, drafting submission sections, and keeping every claim traceable to its source.
- 8x
- faster literature review on target validation
- 40%
- of CSR sections first-drafted by Syntic on partner pilots
- 21 CFR
- Part 11 controls supported
Where Syntic moves the molecule
Research synthesis
Triangulate literature, internal data, and trial readouts into evidence-graded memos.
Regulatory drafting
INDs, CSRs, briefing books — first drafts with citations and tracked rationale.
Trial operations
Protocol deviations, monitoring summaries, and site comms handled with auditability.
Connects to your data
Veeva, EDC systems, internal SharePoints, and licensed literature — wherever the source of truth lives.
Validated workflows
Versioned prompts, frozen models on request, and full review trails for GxP use.
Private deployment
VPC, on-prem, and BAA available; no training on your data.
How teams put it to work
Target validation
Synthesize 10,000+ papers into a ranked landscape your team can act on in days, not months.
Clinical study reports
Draft sections with linked citations and SDTM/ADaM-aware tables your medical writers refine.
Medical affairs
Field-medical briefing docs, KOL summaries, and competitive intelligence at the cadence the field needs.
Regulatory intelligence
Track guidance changes across FDA, EMA, PMDA and notify the right owners.
Capabilities
- 21 CFR Part 11 supporting controls
- GxP-aware audit logging
- Customer data never used for training
- Veeva, IQVIA, EDC integrations
- Region-pinned residency (US, EU, JP)
- Validation evidence package on request
Put AI Employees on your next program
We work with biotechs, top-20 pharma, and CROs. Pick a milestone — we'll scope a 60-day pilot to hit it.